Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in HIV-infected Individuals on ART
NCT04500678Phase 3Terminated
- Sponsor
- University of Hawaiʻi
- Start
- Feb 2019
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in human immunodeficiency virus infection (HIV), sponsored by University of Hawaiʻi. Started Feb 2019; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04500678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04500678.